Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases

Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases

US Patent 9416103 · Granted Aug 16, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of demyelinating diseases2025
Ready-to-extract platforms for chemical analysis and quantification of unknown s2024
PTPRD inhibitors and uses thereof2024
Treatment of demyelinating diseases2022
Method and system for rebate determination and generation2021
Agonists of the mu opioid receptor2021
Antagonists of the kappa opioid receptor2020
Agonists of the mu opioid receptor2018
Antagonists of the kappa opioid receptor2018
Kappa opioid receptor selective compounds, compositions, and uses thereof2018
Kappa opioid receptor effectors and uses thereof2017
Therapeutic compounds2016